Print

Quark Pharmaceuticals Inc. Seeks Up to $20M IPO  
9/27/2010 8:18:19 AM

San Francisco Business Times -- Quark Pharmaceuticals Inc., a developer of RNA interference drugs that signed a big deal last month with Novartis AG, wants to raise up to $20 million in the Bay Area’s latest biotech IPO.
//-->